Indivior Pharmaceuticals, Inc. — Cash Flow Charts
9 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-112.0% -$84M
$-9M
Free Cash Flow↓-141.4% -$99M
$-29M
Investing Cash Flow↓-280.0% -$14M
$-19M
Financing Cash Flow↑+141.2% +$24M
$7M
Capex↑+300.0% +$15M
$20M
Stock Buybacks↑+1045.5% +$115M
$126M
Stock-Based Comp↑+50.0% +$3M
$9M
Debt Issued
$489M
Debt Repaid↑+8225.0% +$329M
$333M
D&A↓-33.3% -$1M
$2M
SBC Allocated Expense↑+50.0% +$3M
$9M